Home › Kanser sa Pantog › California

Pag-aaral pangklinika para sa Kanser sa Pantog sa California

53 pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Tower Cancer Research Foundation, Beverly Hills
City of Hope Corona, Corona
City of Hope Comprehensive Cancer Center, Duarte
at 9 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07061964

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Los Angeles General Medical Center, Los Angeles
at 2 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06770582

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07566156

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
at 1 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Genesis Healthcare-Torrance ( Site 0140), Torrance
at 1 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06833073

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
UCLA Hematology/Oncology - Beverly Hills, Beverly Hills
at 39 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07421700

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

DESTINY-PANTUMOUR04

Research Site, San Diego

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06172478

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
TRIO-US (Translational Research in Oncology-US), Los Angeles
UCLA Hematology/Oncology - Santa Monica, Los Angeles
at 4 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

City of Hope, Duarte
USC/Norris Comprehensive Cancer Center, Los Angeles
UCSF Medical center Parnassus, San Francisco

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

Michael G Oefelein Clinical Trials ( Site 0005), Bakersfield

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07222488

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06465069

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
at 3 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07090499

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Michael G Oefelein, MD Clinical Trials, Bakersfield
City of Hope, Irvine
Genesis Research (Greater Los Angeles), Los Alamitos
at 6 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06567743

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06760819

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
at 20 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05334069

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

UCSF Medical Center at Mission Bay ( Site 5044), San Francisco

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07232602

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Michael Oefelein Clinical Trials, Bakersfield
University of California Irvine Medical Center, Orange
Genesis Research LLC, Torrance

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Michael Oefelein Clinical Trials, Bakersfield

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07480356

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Los Angeles

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07129993

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

City of Hope, Duarte
University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
University of California - Irvine, Orange
at 2 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

Patient-Derived Xenografts to Reduce Cancer Health Disparities

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
University of California Davis Comprehensive Cancer Center, Sacramento

Nagre-recruitObservasyonal na pag-aaral

Edad 21 hanggang 100 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT04410302

Measuring Surgical Recovery After Radical Cystectomy

Stanford University, Stanford

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
at 1 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07097142

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06242470

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

University of California - Irvine Medical Center, Irvine
UC San Diego Moores Cancer Center, La Jolla
USC/Norris Comprehensive Cancer Center, Los Angeles
at 2 pa

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07000084

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Local Institution - 0162, Fullerton
Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto
Sutter Health - Sutter Institute for Medical Research, Sacramento
at 3 pa

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Precision NextGen Oncology & Research Center, Beverly Hills
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
University of California Los Angeles Rheumatology, Westwood, Los Angeles

Nagre-recruitPhase 2

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Kaiser Permanente Anaheim Kraemer Medical Offices, Anaheim
Foothill Cardioology, Arcadia
Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
at 58 pa

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, San Francisco

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07720284

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06580002

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

USC Norris Comprehensive Cancer Center, Los Angeles

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07337525

Predicting BCG Response

Cedars-Sinai Medical Center, Los Angeles
UCLA, Los Angeles
UCSF, San Francisco

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04564781

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Providence Medical Foundation, Anaheim
Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
at 7 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Urology Associates of Central California, Fresno
Urology Group of Southern California, Los Angeles
Comprehensive Urology, Los Angeles

Nagre-recruit

Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06394869

Bladder EpiCheck Product Development Study

Om Research LLC, San Diego

Nagre-recruitObservasyonal na pag-aaral

Edad 22 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT07514143

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.